Kezar Life Sciences, Inc.KZRNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-81.10M
↓ 76% below average
Average (8y)
$-45.96M
Historical baseline
Range
High:$-8.34M
Low:$-99.25M
CAGR
+31.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-81.10M | +18.3% |
| 2023 | $-99.25M | -50.3% |
| 2022 | $-66.03M | -24.7% |
| 2021 | $-52.96M | -31.6% |
| 2020 | $-40.26M | -17.0% |
| 2019 | $-34.42M | -53.1% |
| 2018 | $-22.48M | -169.4% |
| 2017 | $-8.34M | +5.6% |
| 2016 | $-8.84M | - |